Picture of Galecto logo

GLTO Galecto Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Galecto, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-36.5-34.8-51.8-61.6-38.3
Depreciation
Non-Cash Items151.236.056.715.54
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital2.19-4.59-6.6211.9-4.37
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-19.3-38.2-52.3-42.9-36.9
Capital Expenditures-0.223-0.1960
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.3260-47.812.622.3
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.3260-4812.422.3
Financing Cash Flow Items0-4.950
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities018700.5072.88
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-19.6152-101-29.8-11.3